Developing Protein-Based Nanoparticles as Versatile Delivery Systems for Cancer Therapy and Imaging

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Synthetic nanoparticles in cancer nanomedicine show limited clinical success due to poor understanding of bio-nano interactions.
• Protein-based nanoparticles (PNPs) are emerging as promising alternatives for drug and diagnostic agent delivery.

Purpose of the Study:

• To review recent advancements and applications of PNPs in cancer nanomedicine.
• To discuss future research directions and challenges for PNP clinical translation.

Main Methods:

• Literature review of recent advancements in protein-based nanoparticles for cancer nanomedicine.
• Analysis of PNP properties, including abundance, modifiability, monodispersity, biocompatibility, and biodegradability.
• Discussion of engineering strategies for optimal PNP design.

Main Results:

• PNPs present significant advantages over synthetic nanoparticles, including inherent biocompatibility and biodegradability.
• PNPs are versatile platforms for delivering both therapeutic and diagnostic agents in cancer treatment.
• Accurate design and engineering are key to unlocking the full clinical potential of PNPs.

Conclusions:

• PNPs represent a rapidly advancing field with substantial potential to improve cancer nanomedicine outcomes.
• Overcoming current challenges in PNP research and development is essential for successful clinical translation.
• Further investigation into bio-nano interactions will guide the future of PNP-based cancer therapies.